-1.png?width=300&height=58&name=Proscia%20(11)-1.png "Proscia")
A-
Product Grade
Proscia Named Global 2026 Best in KLAS for Digital Pathology in Europe
Best in KLAS is a top distinction in healthcare technology, based solely on customer feedback.
What Earned Customers' Trust
Each year, KLAS gathers input from thousands of healthcare providers, evaluating vendors across six pillars—Product, Operations, Loyalty, Relationship, Value, and Culture—that reflect the realities of deploying and running software to enable the critical diagnoses that guide patient care.
In interviews with KLAS, customers highlighted Concentriq's performance for primary diagnosis at scale and a partnership that delivers long-term impact.
Proven in Daily Diagnostic Workflows
On track for 8M diagnoses, Concentriq is fast, intuitive, and easy to use for primary diagnosis as well as collaboration and consultations. The platform's frequent high-impact releases additionally reinforce customer confidence over time.
Pathology for the Enterprise
Concentriq scales across health systems and laboratory networks with seamless interoperability, backed by proven cloud deployments and 24x7 reliability. It integrates with more than 15 LIS, including Epic Beaker, and serves as a hub for a growing portfolio of AI applications.
Partnership Customers Count On
Customers described Proscia as a dependable partner through implementation and beyond. They highlighted comprehensive training, open communication, and responsive support that helps accelerate time to value.
Value that Earns Commitment
A dependable platform and partner drive strong loyalty. All surveyed Proscia customers see Concentriq as part of their long-term plans.
Key Metrics From Best in KLAS Report
A-
Value Grade
100%
Would Buy Again
About KLAS | KLAS Research, Digital Pathology, 2026
Hear What Our Customers Told KLAS
What is Best in KLAS?
Best in KLAS recognizes top-performing solutions based on customer feedback.
What is KLAS Research?
KLAS Research is a healthcare IT research and insights firm focused on improving healthcare delivery by amplifying the voice of providers (and other healthcare stakeholders). They publish reports, trends, and performance insights based on direct input from the people using healthcare technology day to day.
How does KLAS create its ratings and rankings?
KLAS is “voice-of-the-customer” by design: they conduct 26,000+ in-depth interviews each year with real users–like CIOs, IT leaders, physicians, and administrators—and base rankings on that feedback. KLAS then aggregates results across key dimensions such as product, operations, relationship, value, and loyalty.
What does “Best in KLAS” mean?
“Best in KLAS” is an annual recognition awarded to the #1 solution in a specific market segment, based on customer evaluations gathered over the research period. In each segment, only the top-ranked vendor can claim “Best in KLAS” for that segment and year.
Why do healthcare organizations pay attention to KLAS?
KLAS is widely used to inform purchasing decisions because it reflects what actual customers experience, not marketing claims. KLAS ratings are relied on by more than 20,000 healthcare professionals and are often seen as a strong indicator of customer satisfaction, product maturity, and consistent execution.
See Why Labs Choose Concentriq
Our customers go digital confidently with proven diagnostic workflows, smooth interoperability, and responsive support.
Planning To Go Digital in 2026?
We created a practical buyer's guide for clinical labs evaluating digital pathology systems to help you define requirements before engaging vendors. It covers workflows, IT and integrations, regulatory, hardware, AI readiness, and much more.
Proscia is rewiring pathology for precision medicine to improve patient outcomes. Its technology fuels the development and use of novel therapies and diagnostics, harnessing data and AI in the fight against humanity’s most challenging diseases, like cancer. 16 of the top 20 pharmaceutical companies rely on these solutions each day, and Proscia was named Global 2026 Best in KLAS for Digital Pathology in Europe. For more information, visit proscia.com and follow Proscia on LinkedIn and X.
© Copyright 2026. Proscia Inc., Proscia, Concentriq, Proscia Aperture, the circles logo and Proscia Aperture logo are trademarks or registered trademarks owned by Proscia Inc. All rights reserved.
Concentriq AP-Dx is FDA-cleared for primary diagnosis in the United States (U.S.) with the Hamamatsu NanoZoomer® S360MD Slide scanner and is licensed in Canada and CE‑marked under the EU IVDR for primary diagnosis. Concentriq AP-Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. Concentriq AP and Concentriq LS are for Research Use Only. Not for use in diagnostic procedures.